These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 13427602)
41. [The suitability of propylene glycol (1,2-propanediol) as an active antimicrobial adjuvant in ointments]. Bäurle G; Bieber S; Hornstein OP; Nürnberg E; Muckenschnabel R Z Hautkr; 1985 Aug; 60(15):1198-213. PubMed ID: 3931367 [TBL] [Abstract][Full Text] [Related]
42. [The hypoglycemic action of 2-amino-2-(hydroxymethyl)-1,3-propanediol]. NAHAS GG; LIGOU JC C R Hebd Seances Acad Sci; 1959 Nov; 249():2246-8. PubMed ID: 14425828 [No Abstract] [Full Text] [Related]
43. [Preliminary observations on a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate]. GRANDINETTI P Minerva Med; 1962 Apr; 53():1113-4. PubMed ID: 13901099 [No Abstract] [Full Text] [Related]
44. [Action of 2-amino-2-hydroxymethyl-1,3-propanediol on pancreatic diabetes in the dog]. DOS SJ; NAHAS GG; MITTELMAN A J Physiol (Paris); 1960; 52():80-1. PubMed ID: 13817730 [No Abstract] [Full Text] [Related]
45. [Pharmacological properties of a new synthetic derivative with central depressive activity: 2,2-bis(chloromethyl)-1,3-propanediol (dispranol)]. DELLA BELLA D; ROGNONI F Boll Chim Farm; 1960 Feb; 99():67-78. PubMed ID: 13815673 [No Abstract] [Full Text] [Related]
46. [Inhibitory action of 2-amino-2-(hydroxymethyl)-1, 3-propanediol on the lysis of ribose by nucleotides]. RICCI C; MARINELLO E Boll Soc Ital Biol Sper; 1955 May; 31(5):483-4. PubMed ID: 13269487 [No Abstract] [Full Text] [Related]
47. The enzymatic oxidation of 1,2-propanediol phosphate to acetol phosphate. HUFF E; RUDNEY H J Biol Chem; 1959 May; 234(5):1060-4. PubMed ID: 13654318 [No Abstract] [Full Text] [Related]
48. [Clinical research with a new hypotensive agent: 2-sec-butyl-2-methyl-1,3-propanediol dicarbamate (mebutamate)]. ANNONI G; MAGGI A Minerva Med; 1962 Apr; 53():1108-13. PubMed ID: 13861699 [No Abstract] [Full Text] [Related]
49. [Clinical observations on a new product with hypotensive action (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)]. BOSISIO P; SCAGLIETTI C Minerva Med; 1962 Apr; 53():1101-6. PubMed ID: 13871584 [No Abstract] [Full Text] [Related]
50. [On DL-erythro-2-(o'-carboxy)benzamido-1-p-nitrophenol-1,3-propanediol]. VITA G; DAL CONTE F Farmaco Sci; 1962 Mar; 17():127-9. PubMed ID: 14040062 [No Abstract] [Full Text] [Related]
51. [Clinical evaluation of the hypotensive action of mebutamate (2-sec-butyl-2-methyl-1,3-propanediol dicarbamate)]. MELLONI G; MARANGONI R Minerva Med; 1962 Apr; 53():1085-100. PubMed ID: 14472419 [No Abstract] [Full Text] [Related]
52. [Anti-allergic effects of Merapid]. HONTI G Z Gesamte Inn Med; 1962 Jul; 17():602-3. PubMed ID: 13908734 [No Abstract] [Full Text] [Related]
58. The effect of 2,2-diethyl 1,2-propanediol (a new anticonvulsant) on spinal cord reflexes. SLATER IH; O'LEARY JF; LEARY DE J Pharmacol Exp Ther; 1950 Nov; 100(3):316-24. PubMed ID: 14795389 [No Abstract] [Full Text] [Related]
59. [Could methyl-2-N-propyl-2-propandiolo-1,3-dicarbamate (meprobamate, miltown, perequil) be ultimately used in chronic lead poisoning?]. GENTILE G Folia Med (Napoli); 1959 Jul; 42():819-24. PubMed ID: 13827321 [No Abstract] [Full Text] [Related]
60. Rate of disappearance from the blood and distribution in tissues of 3-(orthotoloxyl)-1,2-propanediol (myanesin). MORRISON JL; RICHARDSON AP; WALKER HA Fed Proc; 1948 Mar; 7(1 Pt 1):246. PubMed ID: 18938577 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]